| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Schoenberg Mark is a Chief Medical Officer at UroGen Pharma Ltd.. Recent SEC Form 4 filings include 1 buy and 14 sells.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 5,153 | $13.08 | $67,401.24 | -3.4% | +4.5% | -44.8% | |
| Mar 18, 2024 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sell | 12,000 | $14.05 | $168,600.00 | -7.9% | +26.1% | -20.5% | |
| Jan 31, 2024 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 3,789 | $15.74 | $59,638.86 | -0.8% | -12.0% | -27.7% | |
| Jan 31, 2023 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 1,900 | $10.12 | $19,228.00 | -0.4% | +37.5% | +51.1% | |
| Oct 31, 2022 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 258 | $11.85 | $3,057.30 | -1.1% | -14.6% | -5.4% | |
| Aug 1, 2022 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 259 | $7.81 | $2,022.79 | -1.1% | +59.3% | +172.8% | |
| Apr 30, 2022 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 254 | $6.62 | $1,681.48 | -1.1% | +11.0% | +102.4% | |
| Jan 31, 2022 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 1,374 | $7.58 | $10,414.92 | -2.9% | -13.7% | +34.6% | |
| Jan 26, 2022 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 111 | $8.09 | $897.99 | -0.5% | -6.8% | +7.6% | |
| Nov 18, 2021 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Buy | 160 | $13.10 | $2,096.00 | +0.7% | -44.7% | -33.0% |